| Accession Number: | 0001062993-23-009594 |
| Date: | 2023-04-27 |
| Issuer: | CARDIOVASCULAR SYSTEMS INC (CSII) |
| Original Submission Date: |
ROSENSTEIN ALEXANDER
1225 OLD HIGHWAY 8 NW
ST. PAUL, MN 55112
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-04-27 | D | 107,700 | d | $20.00 | 40,973 | direct | ||
| COMMON STOCK | 2023-04-27 | D | 40,973 | d | $20.00 | 0 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | pursuant to the agreement and plan of merger by and among cardiovascular systems, inc., a delaware corporation, abbott laboratories, an illinois corporation, and cobra acquisition co., a delaware corporation (the "merger agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. |
| f2 | converted pursuant to the merger agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes. |
